Dow Up 0.54% Nasdaq Up 0.36%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
8.49 Up 0.16(1.92%) 12:13PM EDT - Nasdaq Real Time Price
Prev Close:8.33
Open:8.34
Bid:8.54 x 900
Ask:8.55 x 2500
1y Target Est:7.67
Beta:0.65
Earnings Date:Nov 6 - Nov 10 (Est.)
Day's Range:8.18 - 8.60
52wk Range:7.22 - 10.26
Volume:1,809,315
Avg Vol (3m):3,178,100
Market Cap:1.36B
P/E (ttm):5.13
EPS (ttm):1.65
Div & Yield:0.60 (7.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLIUp 1.92%1.36B
AMGNDown 1.03%110.71B
SGENUp 1.04%4.44B
XOMADown 0.46%465.77M

Key Statistics

Forward P/E (1 yr):3.53
P/S (ttm):3.05
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :2.20
Quarterly EPS Est (Sep-14) :0.61
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.26

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback